127 related articles for article (PubMed ID: 17223543)
1. Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathway.
Baker K; Zlobec I; Tornillo L; Terracciano L; Jass JR; Lugli A
Eur J Cancer; 2007 Feb; 43(3):624-31. PubMed ID: 17223543
[TBL] [Abstract][Full Text] [Related]
2. Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer.
Zlobec I; Lugli A; Baker K; Roth S; Minoo P; Hayashi S; Terracciano L; Jass JR
J Pathol; 2007 Jul; 212(3):260-8. PubMed ID: 17516584
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta pathway disruption and infiltration of colorectal cancers by intraepithelial lymphocytes.
Baker K; Chong G; Foulkes WD; Jass JR
Histopathology; 2006 Oct; 49(4):371-80. PubMed ID: 16978200
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
[TBL] [Abstract][Full Text] [Related]
5. Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer.
Zlobec I; Minoo P; Baker K; Haegert D; Khetani K; Tornillo L; Terracciano L; Jass JR; Lugli A
Eur J Cancer; 2007 Apr; 43(6):1101-7. PubMed ID: 17350821
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status.
Koelzer VH; Baker K; Kassahn D; Baumhoer D; Zlobec I
J Clin Pathol; 2012 Nov; 65(11):996-1002. PubMed ID: 22859396
[TBL] [Abstract][Full Text] [Related]
7. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
8. Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes.
Zlobec I; Terracciano LM; Lugli A
Clin Cancer Res; 2008 Jun; 14(12):3792-7. PubMed ID: 18559598
[TBL] [Abstract][Full Text] [Related]
9. Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.
Zlobec I; Terracciano L; Tornillo L; Günthert U; Vuong T; Jass JR; Lugli A
Gut; 2008 Oct; 57(10):1413-9. PubMed ID: 18436576
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas.
Le Gouvello S; Bastuji-Garin S; Aloulou N; Mansour H; Chaumette MT; Berrehar F; Seikour A; Charachon A; Karoui M; Leroy K; Farcet JP; Sobhani I
Gut; 2008 Jun; 57(6):772-9. PubMed ID: 17965063
[TBL] [Abstract][Full Text] [Related]
11. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.
Minoo P; Zlobec I; Baker K; Tornillo L; Terracciano L; Jass JR; Lugli A
Am J Clin Pathol; 2007 May; 127(5):820-7. PubMed ID: 17439843
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM
Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
Tomsová M; Melichar B; Sedláková I; Steiner I
Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
[TBL] [Abstract][Full Text] [Related]
15. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
Frey DM; Droeser RA; Viehl CT; Zlobec I; Lugli A; Zingg U; Oertli D; Kettelhack C; Terracciano L; Tornillo L
Int J Cancer; 2010 Jun; 126(11):2635-43. PubMed ID: 19856313
[TBL] [Abstract][Full Text] [Related]
16. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
[TBL] [Abstract][Full Text] [Related]
17. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer.
Shia J; Black D; Hummer AJ; Boyd J; Soslow RA
Hum Pathol; 2008 Jan; 39(1):116-25. PubMed ID: 17949789
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
19. Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.
van den Bulk J; Verdegaal EME; Ruano D; Ijsselsteijn ME; Visser M; van der Breggen R; Duhen T; van der Ploeg M; de Vries NL; Oosting J; Peeters KCMJ; Weinberg AD; Farina-Sarasqueta A; van der Burg SH; de Miranda NFCC
Genome Med; 2019 Dec; 11(1):87. PubMed ID: 31888734
[TBL] [Abstract][Full Text] [Related]
20. Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation.
Williams DS; Mouradov D; Newman MR; Amini E; Nickless DK; Fang CG; Palmieri M; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Skinner I; Jones I; Gibbs P; Sieber OM
Mod Pathol; 2020 Jul; 33(7):1420-1432. PubMed ID: 32047231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
